BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7680522)

  • 1. Combined assay of surface immunoglobulin intensity and mouse rosettes. A practical parameter in the differential diagnosis of small lymphocytic and follicular center cell lymphomas.
    Batata A; Shen B
    Am J Clin Pathol; 1993 Mar; 99(3):304-10. PubMed ID: 7680522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse rosettes and surface immunoglobulin in small lymphocytic lymphoma. Importance in immunophenotyping and differential diagnosis.
    Batata A; Shen B
    Cancer; 1992 Feb; 69(4):1021-30. PubMed ID: 1735069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of surface immunoglobulin, mouse rosettes, and CD5 in the immunophenotyping of chronic lymphocytic leukemia and reactive lymphocytosis.
    Batata A; Shen B
    Cancer; 1991 Jul; 68(2):355-61. PubMed ID: 2070335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complementary roles of surface-immunoglobulin clonality and fluorescence intensity, mouse rosettes, and cd5 in the diagnosis of B-chronic lymphocytic-leukemia.
    Batata A; Shen B; Yanes B; Nicholson G; Hines D; Chang J; Gross H; Llenadolee M; Merle S
    Int J Oncol; 1993 Mar; 2(3):425-30. PubMed ID: 21573572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.
    Batata A; Shen B
    Cancer; 1992 Nov; 70(10):2436-43. PubMed ID: 1384948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between chronic lymphocytic leukemia and small lymphocytic lymphoma. A comparative study of membrane phenotypes in 270 cases.
    Batata A; Shen B
    Cancer; 1992 Aug; 70(3):625-32. PubMed ID: 1623477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia with low lymphocyte count.
    Batata A; Shen B
    Cancer; 1993 May; 71(9):2732-8. PubMed ID: 7682147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte immunophenotyping of B-cell lymphomas: a flow cytometric analysis of neoplastic and nonneoplastic cells in 271 cases.
    de Martini RM; Turner RR; Boone DC; Lukes RJ; Parker JW
    Clin Immunol Immunopathol; 1988 Dec; 49(3):365-79. PubMed ID: 2973380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia.
    Koníková E; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody.
    Huh YO; Pugh WC; Kantarjian HM; Stass SA; Cork A; Trujillo JM; Keating MJ
    Am J Clin Pathol; 1994 Mar; 101(3):283-9. PubMed ID: 8135183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two major B cell forms of nodular mixed lymphoma.
    Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
    Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
    Almasri NM; Iturraspe JA; Braylan RC
    Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma.
    Li S; Eshleman JR; Borowitz MJ
    Am J Clin Pathol; 2002 Aug; 118(2):229-34. PubMed ID: 12162683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the low Mr isoform of CD45 (CD45RO) in B-cell non-Hodgkin's lymphomas.
    Caldwell CW; Marty LM; Feldbush TL
    Clin Immunol Immunopathol; 1991 Mar; 58(3):377-84. PubMed ID: 1825807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.